1-20 of 28
Hong-Hu Zhu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL

Xiaosu Zhou, Xue Chen, Jiaqi Chen, Lijun Wen, Zhanglin Zhang, Ya-Zhen Qin, Panxiang Cao, Haizhou Xing, Yingchang Mi, Wei Wang, Guangsen Zhang, Ji Li, Huanling Wu, Zhifen Zhang, Jian Zhang, Zhan Su, Fang Wang, Yang Zhang, Xiaoli Ma, Jiancheng Fang, Ping Wu, Tong Wang, Gaowei Fan, Yang Zhao, David Jin, Xian Zhang, Xiujuan Ma, Qisheng Wu, Zhihua Zhang, Linya Wang, Futian Ma, Xia Xiao, Chengye Wu, Kai Sun, Ruijie Tang, Yun Zhang, Sanyun Wu, Ran Gao, Leping Zhang, Huyong Zheng, Yanli Zhao, Hong-Hu Zhu, Daopei Lu, Peihua Lu, Suning Chen, Hongxing Liu
Journal: Blood
Blood (2024) 144 (14): 1471–1485.
https://doi.org/10.1182/blood.2024023883
Published: 2024
Includes: Supplemental data
Journal Articles

Mitoxantrone Hydrochloride Liposome, Bortezomib, and Dexamethasone- Based Regimen in Multiple Myeloma Patients with Extramedullary Plasmacytoma: A Pilot Study

Yuan Jian, Nian Liu, Yan-Ru Zhang, Wen Gao, Wen-Ming Chen, Hong-Hu Zhu, Yin Wu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6650.
https://doi.org/10.1182/blood-2023-188304
Published: 2023
Journal Articles

APL: Nemo finds its sea anemone

Qian-Fei Wang, Hong-Hu Zhu
Journal: Blood
Blood (2022) 140 (22): 2311–2312.
https://doi.org/10.1182/blood.2022018020
Published: 2022
Journal Articles

Targeting HDAC3 to Overcome the Resistance to ATRA or Arsenic in Acute Promyelocytic Leukemia through Ubiquitination and Degradation of PML-RARα

Bo Dai, Feng Wang, Ying Wang, Jiayan Zhu, Yunxuan Li, Tingting Zhang, Luyao Zhao, Li-Ling Wang, Wenhui GAO, Junmin Li, Aibin Liang, Hong-hu Zhu, Ke Li, Jiong Hu
Journal: Blood
Blood (2022) 140 (Supplement 1): 5924–5925.
https://doi.org/10.1182/blood-2022-156735
Published: 2022
Journal Articles

The ZR2-Minichop Study：Zanubrutinib, Lenalidomide, Rituximab, Cyclophosphamide, Vincristine, Epirubicin and Prednisone in Elderly Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

Jianai Sun, Yi Xu, Min Yang, Huafeng Wang, Wenjuan Yu, Liangshun You, Haitao Meng, Chunmei Yang, Xinping Zhou, Li Li, De Zhou, Xiujing Ye, Hong-hu Zhu, Hongyan Tong, Jie Jin, Wanzhuo Xie
Journal: Blood
Blood (2022) 140 (Supplement 1): 3756.
https://doi.org/10.1182/blood-2022-158723
Published: 2022
Journal Articles

Venetoclax Plus "2 + 5" Modified Intensive Chemotherapy with Daunorubicin and Cytarabine in Fit Elderly Patients with Untreated De Novo Acute Myeloid Leukemia: A Single-Center Retrospective Analysis

Huafeng Wang, Yiyi Yao, Liping Mao, Yinjun Lou, Yanling Ren, Xingnong Ye, Min Yang, Liya Ma, Yi Zhang, Yile Zhou, Xin Huang, Yungui Wang, Huan Xu, Hongyan Tong, Hong-hu Zhu, Jie Jin
Journal: Blood
Blood (2022) 140 (Supplement 1): 3350–3351.
https://doi.org/10.1182/blood-2022-165738
Published: 2022
Journal Articles

Interim Results of a Phase II Study of Dasatinib and Prednisone As an Oral, Chemo-Free Induction and Consolidation Regimen for Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Mixue Xie, Ying Lu, Guifang Ouyang, Liming Zhang, Huixian Hu, Ting Shi, Xueying Li, Xiujing Ye, Jie Jin, Hong-Hu Zhu
Journal: Blood
Blood (2021) 138 (Supplement 1): 4402.
https://doi.org/10.1182/blood-2021-152554
Published: 2021
Journal Articles

Realgar Indigo Formula Plus ATRA As Postremission Treatment in an Rral and Chemo-Free Model for High-Risk Acute Promyelocytic Leukemia Patients: A Prospective, Multicenter, Phase II Study

Hong-hu Zhu, Ya-fang Ma, Suning Chen, Ying Lu, Jiang Huang, Huai-Yu Wang, Xiaohua Xu, Bing-Shou Xie, Yinjun Lou, Jie Jin
Journal: Blood
Blood (2021) 138 (Supplement 1): 873.
https://doi.org/10.1182/blood-2021-149141
Published: 2021
Journal Articles

Venetoclax Combined with Daunorubicin and Cytarabine (DAV) As Induction Therapy in De Novo Young Adult Acute Myeloid Leukemia

Huafeng Wang, Liping Mao, Wanzhuo Xie, Hongyan Tong, Min Yang, Gaixiang Xu, Xiujin Ye, Ying Lu, Juying Wei, Wenyuan Mai, De Zhou, Jie Jin, Hong-Hu Zhu
Journal: Blood
Blood (2021) 138 (Supplement 1): 2334.
https://doi.org/10.1182/blood-2021-153257
Published: 2021
Journal Articles

Ruxolitinib Combined with Dexamethasone in Adult Patients with Secondary HLH：a Single-Centre Pilot Trial

De Zhou, Xianbo Huang, Mixue Xie, Hong-Hu Zhu, Jie Jin, Xiujing Ye
Journal: Blood
Blood (2021) 138 (Supplement 1): 198.
https://doi.org/10.1182/blood-2021-152921
Published: 2021
Journal Articles

Venetoclax-Ponatinib for T315I/Compound-Mutated Ph+Acute Lymphoblastic Leukemia

Huafeng Wang, Jiejing Qian, Chang Yang, Yi Zhang, Yungui Wang, Ting Shi, Yongxian HU, Liping Mao, Xiujin Ye, Fang Liu, Zhenfang Xi, Lihong Shou, Caiyun Fu, Hua Naranmandura, Jie Jin, Hong-Hu Zhu
Journal: Blood
Blood (2021) 138 (Supplement 1): 3395.
https://doi.org/10.1182/blood-2021-152836
Published: 2021
Journal Articles

Clinical Correlation of a Precision Medicine Test with Treatment Outcome in Acute Myeloid Leukemia Patients

Hong-Hu Zhu, MD, Min Ji, MD, Chunyan Ji, MD, Chongwu Wang, Yaqiong Ge, Xiaoping Zhou, Julian Gorrochategui, Daniel Primo, PhD, Joan Ballesteros, PhD, Li Li, MD, Joaquin Martinez-López
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-140252
Published: 2020
Journal Articles

The simpler, the better: oral arsenic for acute promyelocytic leukemia

CME Clinical Trials & Observations
Hong-Hu Zhu, Jiong Hu, Francesco Lo-Coco, Jie Jin
Journal: Blood
Blood (2019) 134 (7): 597–605.
https://doi.org/10.1182/blood.2019000760
Published: 2019
Includes: Supplemental data
Journal Articles

PML Mutation in PML-Rarα Alters PML Nuclear Body Organization and Induces ATRA Resistance in Acute Promyelocytic Leukemia

Hong-Hu Zhu, MD, Congying Wu, Yujie Sun, Jiong Hu, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3923.
https://doi.org/10.1182/blood-2018-99-118310
Published: 2018
Journal Articles

Oral arsenic and all- trans retinoic acid for high-risk acute promyelocytic leukemia

Clinical Trials & Observations
Hong-Hu Zhu, Yan-Rong Liu, Jin-Song Jia, Ya-Zhen Qin, Xiao-Su Zhao, Yue-Yun Lai
Journal: Blood
Blood (2018) 131 (26): 2987–2989.
https://doi.org/10.1182/blood-2018-02-834051
Published: 2018
Includes: Supplemental data
Journal Articles

Efficacy and Safety of Decitabine in Combination with G-CSF, Low-Dose Cytarabine and Aclarubicin in MDS-EB and AML-MRC

Jing Liu, MD PhD, Jinsong Jia, MD, Li-Zhong Gong, MD, Shen-ye Lu, MD, Hong-Hu Zhu, MD, Xiao-Jun Huang, MD, Hao Jiang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2980.
https://doi.org/10.1182/blood.V130.Suppl_1.2980.2980
Published: 2017
Journal Articles

C-KIT- Mutated t(8;21)AML Patients with >3log Reduction of MRD Conferred a Very High Relapse and Need HSCT to Improve Outcome

Hong-Hu Zhu, Ya-Zhen Qin, Lan-Ping Xu, Qian Jiang, MD, Xiao-Hui Zhang, Hao Jiang, MD, Xiao-Jun Huang
Journal: Blood
Blood (2016) 128 (22): 1620.
https://doi.org/10.1182/blood.V128.22.1620.1620
Published: 2016
Journal Articles

The Initial Level of MLL-PTD Affects the Prognosis of Patients with Acute Myeloid Leukemia

Jun Kong, MD, Hao Jiang, MD, Yazhen Qin, Xiaosu Zhao, Dr., Hong-Hu Zhu, MD, Jinsong Jia, MD, Qian Jiang, MD, Jing Wang, MD, Ting Zhao, Xiao-Jun Huang
Journal: Blood
Blood (2016) 128 (22): 5241.
https://doi.org/10.1182/blood.V128.22.5241.5241
Published: 2016
Journal Articles

The Real World of Arsenic Uses in Chinese with Acute Promyelocytic Leukemia: A Cross-Sectional Survey

Hong-Hu Zhu, MD, Feng-Mei Zheng, Xiao-Jun Huang
Journal: Blood
Blood (2016) 128 (22): 5955.
https://doi.org/10.1182/blood.V128.22.5955.5955
Published: 2016
Journal Articles

Varying responses of PML-RARA with different genetic mutations to arsenic trioxide

Clinical Trials & Observations
Jiangying Liu, Hong-Hu Zhu, Hao Jiang, Qian Jiang, Xiao-Jun Huang
Journal: Blood
Blood (2016) 127 (2): 243–250.
https://doi.org/10.1182/blood-2015-04-637678
Published: 2016